<?xml version="1.0" encoding="UTF-8"?>
<p id="p1190">National Institute of Health (NIH) has chosen to generate tetravalent dengue vaccines either by separately introducing 3â€² terminus changes into each of the four DENV or by making structural gene chimeras, including all four sets of dengue antigens or by using a combination of these approaches.</p>
